Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 18 | 2012 | 215 | 2.970 |
Why?
|
| Living Donors | 15 | 2012 | 77 | 1.410 |
Why?
|
| Pandemics | 3 | 2020 | 673 | 1.400 |
Why?
|
| Jehovah's Witnesses | 7 | 2006 | 18 | 1.260 |
Why?
|
| Blood Transfusion | 6 | 2007 | 161 | 1.160 |
Why?
|
| Hepatectomy | 7 | 2016 | 63 | 1.160 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 210 | 1.060 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 224 | 1.050 |
Why?
|
| Liver Neoplasms | 4 | 2016 | 297 | 0.780 |
Why?
|
| Hospitals, Community | 1 | 2022 | 71 | 0.770 |
Why?
|
| Religion and Medicine | 4 | 2005 | 19 | 0.750 |
Why?
|
| Trauma Centers | 1 | 2022 | 123 | 0.740 |
Why?
|
| Graft Survival | 10 | 2012 | 290 | 0.680 |
Why?
|
| Pancreatic Neoplasms | 4 | 2015 | 341 | 0.680 |
Why?
|
| Health Care Rationing | 1 | 2020 | 21 | 0.670 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 14 | 0.660 |
Why?
|
| Government Regulation | 1 | 2020 | 41 | 0.660 |
Why?
|
| Appendicitis | 1 | 2020 | 81 | 0.640 |
Why?
|
| Perioperative Care | 1 | 2020 | 85 | 0.620 |
Why?
|
| Infection Control | 1 | 2020 | 106 | 0.610 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 141 | 0.600 |
Why?
|
| Health Care Costs | 1 | 2020 | 210 | 0.580 |
Why?
|
| Health Policy | 1 | 2020 | 192 | 0.580 |
Why?
|
| Betacoronavirus | 1 | 2020 | 183 | 0.570 |
Why?
|
| Tissue Donors | 4 | 2012 | 152 | 0.560 |
Why?
|
| Tissue and Organ Procurement | 5 | 2012 | 43 | 0.560 |
Why?
|
| Pancreaticoduodenectomy | 2 | 2015 | 64 | 0.560 |
Why?
|
| General Surgery | 1 | 2020 | 210 | 0.540 |
Why?
|
| Endoscopy, Digestive System | 2 | 2015 | 33 | 0.540 |
Why?
|
| Pancreatectomy | 2 | 2015 | 101 | 0.520 |
Why?
|
| Hyperthermia, Induced | 1 | 2016 | 21 | 0.510 |
Why?
|
| Peritoneal Neoplasms | 1 | 2016 | 28 | 0.510 |
Why?
|
| Splenectomy | 2 | 2014 | 42 | 0.500 |
Why?
|
| Retrospective Studies | 13 | 2022 | 6629 | 0.480 |
Why?
|
| Pancreatic Ducts | 1 | 2015 | 30 | 0.480 |
Why?
|
| Intraoperative Care | 1 | 2015 | 38 | 0.480 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 563 | 0.460 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2014 | 16 | 0.450 |
Why?
|
| Blood Platelets | 1 | 2014 | 102 | 0.420 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 280 | 0.410 |
Why?
|
| Duodenum | 2 | 2021 | 42 | 0.400 |
Why?
|
| Humans | 41 | 2022 | 63292 | 0.390 |
Why?
|
| Middle Aged | 22 | 2022 | 17549 | 0.380 |
Why?
|
| Donor Selection | 2 | 2012 | 17 | 0.370 |
Why?
|
| Male | 27 | 2020 | 29814 | 0.350 |
Why?
|
| Treatment Outcome | 14 | 2014 | 5651 | 0.350 |
Why?
|
| Cholestasis | 2 | 2008 | 65 | 0.350 |
Why?
|
| Hospitals, Religious | 1 | 2010 | 2 | 0.350 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 2460 | 0.340 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2009 | 178 | 0.330 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 2008 | 47 | 0.330 |
Why?
|
| Aged | 14 | 2022 | 14390 | 0.330 |
Why?
|
| Female | 27 | 2021 | 32787 | 0.330 |
Why?
|
| Organ Transplantation | 1 | 2010 | 54 | 0.330 |
Why?
|
| Blood Transfusion, Autologous | 2 | 2005 | 6 | 0.300 |
Why?
|
| Aneurysm, False | 2 | 2012 | 50 | 0.300 |
Why?
|
| Biliary Tract | 1 | 2008 | 8 | 0.290 |
Why?
|
| Adult | 16 | 2020 | 16782 | 0.280 |
Why?
|
| Adenocarcinoma | 3 | 2021 | 342 | 0.270 |
Why?
|
| Aged, 80 and over | 7 | 2022 | 5448 | 0.260 |
Why?
|
| Liver Diseases | 2 | 2005 | 155 | 0.260 |
Why?
|
| Hepatic Veins | 1 | 2006 | 13 | 0.250 |
Why?
|
| Adolescent | 7 | 2020 | 6238 | 0.250 |
Why?
|
| Foreign-Body Reaction | 1 | 2005 | 16 | 0.250 |
Why?
|
| Iliac Artery | 1 | 2006 | 49 | 0.240 |
Why?
|
| United States | 8 | 2020 | 7826 | 0.240 |
Why?
|
| Coagulants | 1 | 2005 | 2 | 0.230 |
Why?
|
| Factor VIIa | 1 | 2005 | 3 | 0.230 |
Why?
|
| Amyloidosis | 1 | 2006 | 65 | 0.230 |
Why?
|
| Hemodilution | 4 | 2005 | 11 | 0.230 |
Why?
|
| Postoperative Care | 4 | 2006 | 123 | 0.230 |
Why?
|
| Risk Factors | 8 | 2014 | 5338 | 0.230 |
Why?
|
| Young Adult | 5 | 2020 | 4683 | 0.230 |
Why?
|
| Pancreas | 2 | 2004 | 150 | 0.220 |
Why?
|
| Massachusetts | 2 | 2020 | 2075 | 0.220 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 2003 | 3 | 0.220 |
Why?
|
| Stomach | 1 | 2004 | 86 | 0.220 |
Why?
|
| Stents | 1 | 2008 | 491 | 0.210 |
Why?
|
| Splenic Artery | 1 | 2003 | 9 | 0.210 |
Why?
|
| Postoperative Complications | 4 | 2016 | 1303 | 0.210 |
Why?
|
| Hypertension, Portal | 1 | 2003 | 16 | 0.210 |
Why?
|
| Portal Vein | 1 | 2003 | 38 | 0.210 |
Why?
|
| Emergency Service, Hospital | 2 | 2022 | 1098 | 0.210 |
Why?
|
| Patient Care Team | 2 | 2020 | 337 | 0.200 |
Why?
|
| Aneurysm | 1 | 2003 | 60 | 0.200 |
Why?
|
| Echinococcosis, Hepatic | 1 | 2002 | 5 | 0.200 |
Why?
|
| Survival Rate | 3 | 2016 | 850 | 0.200 |
Why?
|
| Vena Cava, Inferior | 2 | 2017 | 33 | 0.190 |
Why?
|
| Cadaver | 4 | 2006 | 128 | 0.190 |
Why?
|
| Incidence | 2 | 2020 | 1375 | 0.190 |
Why?
|
| Blood Loss, Surgical | 4 | 2006 | 65 | 0.190 |
Why?
|
| Catheter Ablation | 2 | 2016 | 154 | 0.180 |
Why?
|
| Watchful Waiting | 1 | 2021 | 29 | 0.180 |
Why?
|
| Gangrene | 1 | 2020 | 7 | 0.170 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2021 | 33 | 0.170 |
Why?
|
| Time Factors | 7 | 2012 | 3759 | 0.170 |
Why?
|
| Feasibility Studies | 1 | 2022 | 568 | 0.170 |
Why?
|
| Liver Cirrhosis | 3 | 2009 | 171 | 0.170 |
Why?
|
| Appendectomy | 1 | 2020 | 54 | 0.170 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 163 | 0.160 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 111 | 0.160 |
Why?
|
| Emergencies | 1 | 2020 | 116 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2014 | 1618 | 0.160 |
Why?
|
| Reoperation | 3 | 2012 | 289 | 0.160 |
Why?
|
| Clinical Protocols | 1 | 2020 | 139 | 0.150 |
Why?
|
| Pilot Projects | 1 | 2022 | 1006 | 0.150 |
Why?
|
| Referral and Consultation | 1 | 2022 | 422 | 0.150 |
Why?
|
| Chi-Square Distribution | 4 | 2012 | 417 | 0.150 |
Why?
|
| Constriction, Pathologic | 2 | 2008 | 129 | 0.140 |
Why?
|
| Peritoneum | 1 | 2017 | 30 | 0.130 |
Why?
|
| Abdominal Neoplasms | 1 | 2017 | 22 | 0.130 |
Why?
|
| Liver | 3 | 2008 | 851 | 0.130 |
Why?
|
| Infusions, Parenteral | 1 | 2016 | 22 | 0.130 |
Why?
|
| Organoplatinum Compounds | 1 | 2016 | 21 | 0.130 |
Why?
|
| Mitomycin | 1 | 2016 | 26 | 0.130 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 11 | 0.130 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2016 | 36 | 0.130 |
Why?
|
| Anastomosis, Surgical | 2 | 2008 | 114 | 0.130 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 242 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 372 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2012 | 422 | 0.120 |
Why?
|
| Preoperative Care | 3 | 2007 | 192 | 0.120 |
Why?
|
| Liver Circulation | 2 | 2006 | 11 | 0.120 |
Why?
|
| Choledochal Cyst | 1 | 2014 | 3 | 0.120 |
Why?
|
| Length of Stay | 4 | 2014 | 811 | 0.120 |
Why?
|
| Liver Failure | 2 | 2005 | 18 | 0.120 |
Why?
|
| Graft Rejection | 2 | 2007 | 293 | 0.110 |
Why?
|
| Platelet Count | 1 | 2014 | 26 | 0.110 |
Why?
|
| Algorithms | 1 | 2020 | 1001 | 0.110 |
Why?
|
| Nephrectomy | 2 | 2007 | 91 | 0.110 |
Why?
|
| Risk Assessment | 4 | 2012 | 2071 | 0.110 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2014 | 50 | 0.110 |
Why?
|
| Databases as Topic | 2 | 2011 | 55 | 0.110 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 129 | 0.110 |
Why?
|
| Biopsy | 1 | 2015 | 444 | 0.110 |
Why?
|
| Bone Marrow | 1 | 2014 | 178 | 0.100 |
Why?
|
| Kidney Transplantation | 2 | 2007 | 319 | 0.100 |
Why?
|
| Vascular Patency | 2 | 2017 | 139 | 0.090 |
Why?
|
| Health Resources | 1 | 2012 | 95 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2012 | 78 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 663 | 0.090 |
Why?
|
| Oklahoma | 1 | 2010 | 6 | 0.090 |
Why?
|
| Embolization, Therapeutic | 2 | 2004 | 316 | 0.080 |
Why?
|
| Total Quality Management | 1 | 2010 | 56 | 0.080 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 317 | 0.080 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 243 | 0.080 |
Why?
|
| Models, Organizational | 1 | 2010 | 93 | 0.080 |
Why?
|
| alpha-Fetoproteins | 1 | 2009 | 15 | 0.080 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2009 | 11 | 0.080 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2009 | 19 | 0.080 |
Why?
|
| Hepatitis B | 1 | 2009 | 32 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 1 | 2012 | 337 | 0.080 |
Why?
|
| Cause of Death | 2 | 2012 | 221 | 0.080 |
Why?
|
| Continuity of Patient Care | 1 | 2010 | 174 | 0.080 |
Why?
|
| Hepatic Duct, Common | 1 | 2008 | 7 | 0.070 |
Why?
|
| Cholangiography | 1 | 2008 | 42 | 0.070 |
Why?
|
| Global Health | 1 | 2009 | 183 | 0.070 |
Why?
|
| Bile Ducts | 1 | 2008 | 25 | 0.070 |
Why?
|
| Program Evaluation | 1 | 2010 | 488 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2009 | 151 | 0.070 |
Why?
|
| Catheterization | 1 | 2008 | 111 | 0.070 |
Why?
|
| Risk | 1 | 2008 | 377 | 0.070 |
Why?
|
| CA-19-9 Antigen | 1 | 2007 | 10 | 0.070 |
Why?
|
| Endoscopy | 1 | 2008 | 110 | 0.070 |
Why?
|
| Xanthomatosis | 1 | 2007 | 8 | 0.070 |
Why?
|
| Jejunal Neoplasms | 1 | 2007 | 3 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2014 | 1988 | 0.070 |
Why?
|
| Granuloma | 1 | 2007 | 41 | 0.070 |
Why?
|
| Cholecystitis | 1 | 2007 | 29 | 0.070 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2007 | 16 | 0.070 |
Why?
|
| Equipment Design | 1 | 2008 | 349 | 0.070 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2007 | 20 | 0.070 |
Why?
|
| Celiac Artery | 1 | 2006 | 14 | 0.060 |
Why?
|
| Death | 1 | 2006 | 30 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2008 | 192 | 0.060 |
Why?
|
| Age Factors | 1 | 2010 | 1560 | 0.060 |
Why?
|
| Liver Regeneration | 1 | 2006 | 19 | 0.060 |
Why?
|
| Laparotomy | 1 | 2005 | 52 | 0.060 |
Why?
|
| Erythropoietin | 1 | 2005 | 39 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 1146 | 0.060 |
Why?
|
| Blood Volume | 1 | 2005 | 42 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2004 | 25 | 0.060 |
Why?
|
| Probability | 1 | 2004 | 170 | 0.050 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2004 | 13 | 0.050 |
Why?
|
| Hematocrit | 1 | 2004 | 34 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 138 | 0.050 |
Why?
|
| Reference Values | 1 | 2004 | 335 | 0.050 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2005 | 69 | 0.050 |
Why?
|
| Blood Component Transfusion | 1 | 2003 | 11 | 0.050 |
Why?
|
| Anemia | 1 | 2005 | 127 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 506 | 0.050 |
Why?
|
| Plasma | 1 | 2003 | 37 | 0.050 |
Why?
|
| Albendazole | 1 | 2002 | 10 | 0.050 |
Why?
|
| APACHE | 1 | 2002 | 43 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 701 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2003 | 185 | 0.050 |
Why?
|
| Anthelmintics | 1 | 2002 | 44 | 0.050 |
Why?
|
| Decompression, Surgical | 1 | 2002 | 69 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2017 | 278 | 0.050 |
Why?
|
| Pancreatitis | 1 | 2002 | 97 | 0.050 |
Why?
|
| Drainage | 1 | 2002 | 154 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1121 | 0.040 |
Why?
|
| Patient Admission | 1 | 2002 | 195 | 0.040 |
Why?
|
| Advance Care Planning | 1 | 2021 | 62 | 0.040 |
Why?
|
| Infant | 1 | 2005 | 1649 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2012 | 730 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2003 | 491 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2017 | 127 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 92 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2012 | 126 | 0.020 |
Why?
|
| Child | 2 | 2014 | 4522 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 548 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 935 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2012 | 866 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2012 | 406 | 0.020 |
Why?
|
| Registries | 1 | 2012 | 886 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2012 | 874 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 2007 | 34 | 0.020 |
Why?
|
| Treatment Refusal | 1 | 2007 | 56 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 972 | 0.010 |
Why?
|
| Multiple Organ Failure | 1 | 2002 | 44 | 0.010 |
Why?
|
| Necrosis | 1 | 2002 | 143 | 0.010 |
Why?
|
| Pain, Postoperative | 1 | 2003 | 163 | 0.010 |
Why?
|
| Acute Disease | 1 | 2002 | 672 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2003 | 863 | 0.010 |
Why?
|
| Prognosis | 1 | 2002 | 1750 | 0.010 |
Why?
|